Rankings
▼
Calendar
▼
SLS Q4 2015 Earnings Report — SELLAS Life Sciences Group, Inc. Revenue & Financial Results | Market Cap Arena
SELLAS Life Sciences Group, Inc.
SLS
Q4 2015 Earnings
Reported March 10, 2016
Quarter Comparison
Revenue
Operating Income
Gross Margin
Net Margin
EPS (Diluted)
Metric
Q4 2015
Q3 2015
Q4 2014
QoQ Change
YoY Change
Revenue
-$6M
—
—
—
—
Op. Income
-$8M
—
—
—
—
Gross Margin
114.0%
—
—
—
—
Net Margin
320.9%
—
—
—
—
EPS (Diluted)
$-405.20
—
—
—
—
marketcaparena.com
Income Statement
Item
Amount
REVENUE
-$6M
Cost of Revenue
$861.0K
GROSS PROFIT
-$7M
R&D Expenses
$5M
Selling & Marketing
$0
General & Administrative
$3M
SG&A Expenses
$3M
Other Expenses
$440.0K
Operating Expenses
$8M
Cost & Expenses
$8M
OPERATING INCOME
-$8M
Interest Income
$0
Interest Expense
$153.0K
Other Income/Expenses
-$3M
INCOME BEFORE TAX
-$10M
Income Tax Expense
$365.0K
Net Income from Continuing Ops
-$11M
Net Income from Discontinued Ops
-$9M
Other Adjustments
$0
NET INCOME
-$20M
Net Income Deductions
$0
BOTTOM LINE NET INCOME
-$20M
D&A
$51.0K
EBIT
-$8M
EBITDA
-$8M
EPS
-$405
EPS Diluted
-$405
marketcaparena.com
← FY 2014
SLS Overview
FY 2017 →